Theoretical and literary evidence for the existence of the passive antitumor defence system

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 4, 1997, Pages 281-286

  Kulcsár, Gyula ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Immune response in AIDS; Immune system; PADS; Passive antitumor defence system; Small substances of the circulatory system; Synergistic tumour cell killing effect

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER INHIBITION; HUMAN; IMMUNE RESPONSE; NUTRITION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

EID: 0031473077     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.281     Document Type: Article

References (62)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617.
2. Reif AE. Immunosurveillance reevaluated in light of AIDS. In: Lectures and Symposia 14th In. Cancer Congr. Budapest 1986. Lapis K, Eckhardt S. (eds) Karger, Basel/ Akadémiai Kiadó, Budapest, 1987; 5:321.
3. Kalish RS, Schlossman SF. The T4 lymphocyte in AIDS. N Engl J Med 1985;313:112.
4. Zunich KM, Lane HC. Immunologic abnormalities in HIV infection. Hematol Oncol Clin N Am 1991;5:215.
5. Brenner BG, Gryllis C, Gornitsky M, Cupples W, Wainberg M. Differential effects of chemotherapy-induced and HIV-1-induced immunocompromise on NK and LAK activities using breast cancer and HIV-1 seropositive patient populations. Anticancer Res 1991; 11:969.
6. Gootenberg JE, Stewart CL, Vetro SW, Bellanti JA. Lack of graft rejection in a renal transplant recipient with AIDS Ann Allergy 1991;67:123
7. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 1991;47:692.
8. Rabkin CS, Blattner WA. HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma. Cancer Surv 1991;10:151.
9. Casabona J, Melbye M, Biggar RJ, and the AIDS Registry Contributors. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. Int J Cancer 1991;47:49.
10. Schechter MT, Marion SA, Elmslie KD, Ricketts MN, Nault P, Archibald CP. Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada. Am J Epidemiol 1991;134:485.
11. Haverkos HW, Drotman DP, Morgan M. Prevalence of Kaposi's sarcoma among patients with AIDS N Engl J Med 1985;312:1518
12. Mueller BU, Butler KM, Higham MC, et al. Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1992;90:460.
13. Hewitt HB. Failure of cancer research J Royal Soc Med 1991;84:321.
14. Dawson M, Moore M. Tumour immunology In: Immunology, Roitt IM, Brostoff J, Male DK. (eds) Gower Medical Publishing, London, 1989;18:1.
15. Perm I. Cancer in the immunosuppressed organ recipient. Transplant Proc 1991;23:1771.
16. Hokama Y, Nakamura RM. Immunology and Immunopathology Little, Brown & Co., Boston, 1982.
17. Fodstad Ø, Hansen CT, Cannon GB, Statham CN, Lichtenstein GR, Boyd MR. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects. Cancer Res 1984;44:4403.
18. Zarling JM, Bach FH. Continuous culture of T cells cytotoxic for autologous human leukemia cells. Nature 1979;280:685.
19. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors Am J Epidemiol 1992;136:54.
20. Kitamura K, Mitsudomi T, Ishida T, Kaneko S, Sugimachi K. Adenocarcinoma and squamous cell carcinoma in the same lobe of the lung. Respiration 1991,58:226.
21. Wallach DFH. Membrane permeability. In. Membrane Molecular Biology of Neoplastic Cells, Wallach DFH, Schmidt-Ullrich R. (eds) Elsevier Scientific Publishing Co., Amsterdam, 1975;293.
22. Roberts E, Simonsen DG, Kihara H, Tanaka KK. Influence of intraperitoneally administered amino acids on amino acid patterns of ehrlich ascites tumor cells and brain in mice Biochem Pharmacol 1966,15:615.
23. Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: A review. Cancer Res 1979;39:663.
24. Merrill AH, Jr Foltz AT, McCormick DB. Vitamins and cancer. In: Cancer and Nutrition, Alfin-Slater RB, Kritchevsky D. (eds) Plenum Publishing Co., New York, 1991;7:261.
25. Medina MÁ, Márquez J, Núñez de Castro I. Interchange of amino acids between tumor and host. Biochem Med Metab Biol 1992;48:1.
26. Hokama Y, Nakamura RM. The immune system: cellular basis. In. Immunology and Immunopathology, Hokama Y, Nakamura RM. (eds) Little, Brown & Co, Boston, 1982;1.
27. Kulcsár Gy. Inhibition of the growth of a murine and various human tumor cell lines in culture and in mice by mixture of certain substances of the circulatory system. Cancer Biotherapy 1995;10:157.
28. Kulcsár Gy. Passive Antitumor Defense System: a New Approach. Cell Biol Int 1996;20:228.
29. Kulcsár Gy. Apoptosis of Tumor Cells Induced by Substances of the Circulatory System. Cancer Biotherapy & Radiopharmaceuticals 1997,12:19.
30. Block G, Patterson B, Subar A Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 1992;18:1.
31. Nomura AMY, Kolonel LN, Hankin JH, Yoshizawa CN. Dietary factors in cancer of the lower urinary tract. Int J Cancer 1991;48:199.
32. Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991;53:270S
33. Diamond J Evolutionary design of intestinal nutrient absorption: enough but not too much. News Physiol Sci 1991;6:92.
34. Bergström J, Fürst P, Vinnars E. Effect of a test meal, without and with protein, on muscle and plasma free amino acids. Clinical Sci 1990;79:331.
35. Tuyns AJ. Alcohol and cancer. An instructive association. Br J Cancer 1991;64:415.
36. Blot WJ. Alcohol and cancer. Cancer Res 1992; Suppl.52:2119s.
37. Watzl B, Watson RR. Role of alcohol abuse in nutritional immunosuppression. J Nutr 1992;122:733.
38. Lieber CS. Alcohol, liver, and nutrition. J Am Coll Nutr 1991;10:602.
39. Steel GG. Cell loss as a factor in the growth rate of human tumours. Europ J Cancer 1967;3.381.
40. Stockdale FE. Cancer growth and chemotherapy. In: Scientific American Medicine, Rubenstein E, Federman DD. (eds) Scientific American, New York, 1984; 2,12(V):1.
41. Karnad AB, Jaffar A, Lands RH. Spontaneous regression of acquired immune deficiency syndrome-related, high-grade, extranoda non-Hodgkin's lymphoma. Cancer 1992;69:1586.
42. Real FX, Krown SE. Spontaneous regression of Kaposi's sarcoma in patients with AIDS. N Engl J Med 1985;313:1659.
43. Andrews EJ. Evidence of the nonimmune regression of chemically induced papillomas in mouse skin. J Natl Cancer Inst 1971;47:653.
44. Fidler IJ. Cancer metastasis. Br Med Bull 1991;47:157.
45. Liotta LA. The biology of metastasis. In: Textbook of Internal Medicine, Kelley WN, DeVita VT, DuPont HL, Harris ED, Hazzard WR, Holmes EW, Hudson LD, Humes HD, Paty DW, Watanabe AM, Yamada T. (eds) J.B Lippincott Co , Philadelphia, 1989;1144.
46. Tarin D, Price JE, Kettlewell MGW, Souter RG, Vass ACR, Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 1984;44:3584.
47. Tarin D, Price JE, Kettlewell MGW, Souter RG, Vass ACR, Crossley B. Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. Br Med J 1984;288:749
48. Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites Biochim Biophys Acta 1988;948:175.
49. Weiss L. Deformation-driven, lethal damage to cancer cells. Cell Biophysics 1991,18.73.
50. Zietman AL, Suit HD, Ramsay JR, Silobrcic V, Sedlacek RS. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Res 1988,48:6510.
51. Campos ACL, Waitzberg DL, Meguid MM. A comparison of the changes in carbohydrate, fat, and protein metabolism occurring with malignant and benign tumors and the impact of nutritional support. In: Cancer and Nutrition, Alfin-Slater RB, Kritchevsky D (eds) Plenum Publishing Co., New York, 1991;7:69.
52. Mansi JL, Berger U, McDonnell T, et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989;7:445.
53. Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G H. A. Clowes memorial award lecture. Cancer Res 1990;50:6130.
54. Horak E, Darling DL, Tarin D. Analysis of organ-specific effects on metastatic tumor formation by studies in vitro. J Natl Cancer Inst 1986;76:913.
55. Szaniawska B, Majewski S, Kaminski MJ, Noremberg K, Swierz M, Janik P. Stimulatory and inhibitory activities of lung-conditioned medium on the growth of normal and neoplastic cells in vitro. J Natl Cancer Inst 1985,75:303.
56. Hartwig M. Immune ageing and cancer. Eur J Cancer 1992;28A:1939
57. Yancik R, Ries LG. Cancer in the aged. Cancer 1991; 68:2502.
58. Young EA. Nutrition, aging, and the aged. Med Clin North Am 1983;67:295
59. Morley JE. Nutritional status of the elderly Am J Med 1986;81:679.
60. Vinardell MP. Age influences on amino acid intestinal transport. Comp Biochem Physiol 1992;103A:169.
61. Sarwar G, Botting HG, Collins M. A comparison of fasting serum amino acid profiles of young and elderly subjects. J Am Coll Nutr 1991;10:668.
62. Manson A, Shea S. Malnutrition in elderly ambulatory medical patients. Am J Public Health 1991;81:1195.